Original Research
Accepted on 29 Jan 2025
Multimodal Fusion Model for Diagnosing Mild Cognitive Impairment in Unilateral Middle Cerebral Artery Steno-occlusive Disease
Frontiers in Aging Neuroscience
doi 10.3389/fnagi.2025.1527323
Volumes
7,012 Publications
Volume 17 - 2025
Original Research
Published on 29 Jan 2025
Development and internal validation of a nomogram for predicting cognitive impairment after mild ischemic stroke and transient ischemic attack based on cognitive trajectories: a prospective cohort study
Frontiers in Aging Neuroscience
doi 10.3389/fnagi.2025.1427737
- 158 views
Review
Published on 29 Jan 2025
Multi-functional role of apolipoprotein E in neurodegenerative diseases
Frontiers in Aging Neuroscience
doi 10.3389/fnagi.2025.1535280
- 110 views
Mini Review
Published on 29 Jan 2025
From hypoxic pockets to daily routines: linking brain oxygenation and cognitive resilience
Frontiers in Aging Neuroscience
doi 10.3389/fnagi.2025.1534198
- 140 views
Correction
Accepted on 28 Jan 2025
Multidimensional Features of Sporadic Creutzfeldt-Jakob Disease in the Elderly: A Case Report and Systematic Review
Frontiers in Aging Neuroscience
doi 10.3389/fnagi.2025.1565464
Original Research
Accepted on 28 Jan 2025
Delirium following mechanical thrombectomy for ischemic stroke - individuals at risk, imaging biomarkers and prognosis
Frontiers in Aging Neuroscience
doi 10.3389/fnagi.2025.1486726
Systematic Review
Accepted on 28 Jan 2025
Functional and effective EEG connectivity patterns in Alzheimer's disease and mild cognitive impairment: A systematic review
Frontiers in Aging Neuroscience
doi 10.3389/fnagi.2025.1496235
Original Research
Accepted on 28 Jan 2025
Quantification and correlation of amyloid-β plaque load, glial activation, GABAergic interneuron numbers and cognitive decline in the young TgF344-AD rat model of Alzheimer's disease
Frontiers in Aging Neuroscience
doi 10.3389/fnagi.2025.1542229
Original Research
Accepted on 28 Jan 2025
Deciphering novel mitochondrial signatures: multi-omics analysis uncovers cross-disease markers and oligodendrocyte pathways in Alzheimer's disease and Glioblastoma
Frontiers in Aging Neuroscience
doi 10.3389/fnagi.2025.1536142
Original Research
Published on 28 Jan 2025
Hypertension moderates the relationship between plasma beta-amyloid and cognitive impairment: a cross-sectional study in Xi’an, China
Frontiers in Aging Neuroscience
doi 10.3389/fnagi.2025.1532676
- 233 views
Review
Accepted on 27 Jan 2025
Non-pharmacological Treatment of Alzheimer's Disease: An update
Frontiers in Aging Neuroscience
doi 10.3389/fnagi.2025.1527242
Original Research
Accepted on 27 Jan 2025
Research Article: Relationships of hematocrit concentration with dementia from a multiethnic population-based study
Frontiers in Aging Neuroscience
doi 10.3389/fnagi.2025.1543798
Original Research
Accepted on 27 Jan 2025
A Simple and Effective Screening Strategy for Early Multiple System Atrophy Diagnosis and α-Synuclein forms in Erythrocytes
Frontiers in Aging Neuroscience
doi 10.3389/fnagi.2025.1533504
Original Research
Accepted on 27 Jan 2025
Stools from a human APOEe2 donor reduces amyloid and tau pathology and increases neuroinflammation in a 3xTg AD mouse model
Frontiers in Aging Neuroscience
doi 10.3389/fnagi.2025.1539067
Original Research
Published on 27 Jan 2025
Untargeted urine metabolomics reveals dynamic metabolic differences and key biomarkers across different stages of Alzheimer’s disease
Frontiers in Aging Neuroscience
doi 10.3389/fnagi.2025.1530046
- 307 views